Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Sarcoidosis and Genetics, with related work in Phenotype, Idiopathic pulmonary fibrosis, Genome-wide association study. Notable publications include 'Phenotypes of organ involvement in sarcoidosis', 'Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis', and 'Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis'.
Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis
Gender specific airway gene expression in COPD sub-phenotypes supports a role of mitochondria and of different types of leukocytes
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose
A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation
High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controls
Phenotypes of organ involvement in sarcoidosis
German Guideline for Idiopathic Pulmonary Fibrosis – Update on Pharmacological Therapies 2017
Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome
S2k-Leitlinie Idiopathische Lungenfibrose – Update zur medikamentösen Therapie 2017
Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography
Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk
High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences
Positionspapier zur Bedeutung der forcierten Vitalkapazität für Patienten mit idiopathischer Lungenfibrose (IPF)
S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose
Circulating cytokines in sarcoidosis: Phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease
A Novel Sarcoidosis Risk Locus for Europeans on Chromosome 11q13.1